Elevated neutrophil‐to‐lymphocyte ratio (NLR) is associated with poorer progression‐free survival in unresectable stage III NSCLC treated with consolidation durvalumab

Sustained elevation in neutrophil‐to‐lymphocyte ratio (NLR) after initial chemoradiotherapy (CRT) has been shown to correlate with worse prognosis in a number of solid organ malignancies. Here, we conducted a retrospective observational cohort study involving six sites across Sydney, Australia, incl...

Descripción completa

Detalles Bibliográficos
Autores principales: Nindra, Udit, Shahnam, Adel, Stevens, Samuel, Pal, Abhijit, Nagrial, Adnan, Lee, Jenny, Yip, Po Yee, Adam, Tamiem, Boyer, Michael, Kao, Steven, Bray, Victoria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2022
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9626316/
https://www.ncbi.nlm.nih.gov/pubmed/36111516
http://dx.doi.org/10.1111/1759-7714.14646

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9626316/
https://www.ncbi.nlm.nih.gov/pubmed/36111516
http://dx.doi.org/10.1111/1759-7714.14646

Ejemplares similares